{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:40:40Z","timestamp":1790797240744,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009794","name":"Breast Cancer Now","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.canlet.2020.05.021","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T18:10:48Z","timestamp":1590689448000},"page":"27-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis"],"prefix":"10.1016","volume":"488","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1332-4798","authenticated-orcid":false,"given":"Ryan T.","family":"Bishop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3695-0908","authenticated-orcid":false,"given":"Silvia","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0382-4334","authenticated-orcid":false,"given":"Giovana","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2135-2649","authenticated-orcid":false,"given":"Anna","family":"Sparatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope D.","family":"Ottewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mollat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Capulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4327-5306","authenticated-orcid":false,"given":"Aymen I.","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.05.021_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1242\/jcs.115.4.679","article-title":"All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction","volume":"115","author":"Chung","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2020.05.021_bib2","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1038\/sj.onc.1204788","article-title":"Tumor necrosis factor receptor-associated factors (TRAFs)","volume":"20","author":"Bradley","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2020.05.021_bib3","doi-asserted-by":"crossref","first-page":"10168","DOI":"10.1021\/bi9909905","article-title":"High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization","volume":"38","author":"Pullen","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.canlet.2020.05.021_bib4","doi-asserted-by":"crossref","first-page":"44347","DOI":"10.1074\/jbc.M202009200","article-title":"A RANK\/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function","volume":"277","author":"Armstrong","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2020.05.021_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-291X(03)00695-8","article-title":"Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts","volume":"305","author":"Lee","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2020.05.021_bib6","doi-asserted-by":"crossref","first-page":"8799","DOI":"10.1074\/jbc.273.15.8799","article-title":"Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1","volume":"273","author":"Jimi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2020.05.021_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/15216540500137669","article-title":"RANKing intracellular signaling in osteoclasts","volume":"57","author":"Feng","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.canlet.2020.05.021_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.05.021_bib9","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.05.021_bib10","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1073\/pnas.200294797","article-title":"Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene","volume":"97","author":"Kim","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.05.021_bib11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.emboj.7600564","article-title":"RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis","volume":"24","author":"Gohda","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2020.05.021_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.embor.7400345","article-title":"Strength of TRAF6 signalling determines osteoclastogenesis","volume":"6","author":"Kadono","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2020.05.021_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2443.2005.00852.x","article-title":"TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway","volume":"10","author":"Kishida","year":"2005","journal-title":"Gene Cell."},{"key":"10.1016\/j.canlet.2020.05.021_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/MCB.22.4.992-1000.2002","article-title":"Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6","volume":"22","author":"Mizukami","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2020.05.021_bib15","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bbrc.2007.06.017","article-title":"TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation","volume":"359","author":"Lamothe","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2020.05.021_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0092-8674(00)00126-4","article-title":"Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain","volume":"103","author":"Deng","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.05.021_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2407-6-179","article-title":"Clinical management of women with metastatic breast cancer: a descriptive study according to age group","volume":"6","author":"Manders","year":"2006","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2020.05.021_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ncb3445","article-title":"A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1alpha activation, tumorigenesis and metastasis","volume":"19","author":"Rezaeian","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2020.05.021_bib19","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/cas.14012","article-title":"Tumor necrosis factor receptor-associated factor 6 contributes to malignant behavior of human cancers through promoting AKT ubiquitination and phosphorylation","volume":"110","author":"Shi","year":"2019","journal-title":"Canc. Sci."},{"key":"10.1016\/j.canlet.2020.05.021_bib20","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41419-019-2187-8","article-title":"TLR5: a prognostic and monitoring indicator for triple-negative breast cancer","volume":"10","author":"Shi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2020.05.021_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2017.08.021","article-title":"Up-regulation of OLR1 expression by TBC1D3 through activation of TNFalpha\/NF-kappaB pathway promotes the migration of human breast cancer cells","volume":"408","author":"Wang","year":"2017","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2020.05.021_bib22","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3892\/mmr.2017.6782","article-title":"Regulatory role of tumor necrosis factor receptor-associated factor 6 in breast cancer by activating the protein kinase B\/glycogen synthase kinase 3beta signaling pathway","volume":"16","author":"Shen","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2020.05.021_bib23","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3892\/ol.2015.3094","article-title":"Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer","volume":"9","author":"Bilir","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.canlet.2020.05.021_bib24","doi-asserted-by":"crossref","first-page":"dju012","DOI":"10.1093\/jnci\/dju012","article-title":"Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis","volume":"106","author":"Lin","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2020.05.021_bib25","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2174\/156652412802480871","article-title":"Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment","volume":"12","author":"Li","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.canlet.2020.05.021_bib26","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1074\/jbc.M511153200","article-title":"Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2020.05.021_bib27","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/1471-2091-8-S1-S14","article-title":"Patented small molecule inhibitors in the ubiquitin proteasome system","volume":"8","author":"Guedat","year":"2007","journal-title":"BMC Biochem."},{"key":"10.1016\/j.canlet.2020.05.021_bib28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.05.021_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019234","article-title":"Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients","volume":"6","author":"Santini","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.canlet.2020.05.021_bib30","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1158\/1078-0432.CCR-18-2202","article-title":"Endogenous production of IL1B by breast cancer cells drives metastasis and colonization of the bone microenvironment","volume":"25","author":"Tulotta","year":"2019","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.05.021_bib31","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1038\/s41467-019-12807-0","article-title":"Microenvironmental IL1beta promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling","volume":"10","author":"Eyre","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2020.05.021_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10585-013-9624-3","article-title":"RANK expression on breast cancer cells promotes skeletal metastasis","volume":"31","author":"Blake","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2020.05.021_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-018-0036-5","article-title":"Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis","volume":"7","author":"Nakai","year":"2019","journal-title":"Bone Res"},{"key":"10.1016\/j.canlet.2020.05.021_bib34","article-title":"RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation","author":"Tang","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2020.05.021_bib35","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1158\/0008-5472.CAN-09-2758","article-title":"Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer\/CD147","volume":"70","author":"Rucci","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.05.021_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.1199","article-title":"RANK ligand is a prerequisite for cancer-associated osteolytic lesions","volume":"198","author":"Kitazawa","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2020.05.021_bib37","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2020.05.021_bib38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/ci500631e","article-title":"Discovery of small molecule CD40-TRAF6 inhibitors","volume":"55","author":"Zarzycka","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.canlet.2020.05.021_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature00888","article-title":"Distinct molecular mechanism for initiating TRAF6 signalling","volume":"418","author":"Ye","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.05.021_bib40","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3389\/fimmu.2018.01999","article-title":"Structure of TRAF family: current understanding of receptor recognition","volume":"9","author":"Park","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2020.05.021_bib41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/978-0-387-70630-6_12","article-title":"TRAFs in RANK signaling","volume":"597","author":"Darnay","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.canlet.2020.05.021_bib42","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/jbmr.1686","article-title":"Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs","volume":"27","author":"Capulli","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2020.05.021_bib43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1530\/ERC-13-0158","article-title":"Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line","volume":"21","author":"Nutter","year":"2014","journal-title":"Endocr. Relat. Canc."},{"key":"10.1016\/j.canlet.2020.05.021_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-4939-8997-3_5","article-title":"2D and 3D in vitro Co-culture for cancer and bone cell interaction studies","volume":"1914","author":"Marino","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2020.05.021_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejphar.2008.11.023","article-title":"The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action","volume":"602","author":"Idris","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2020.05.021_bib46","doi-asserted-by":"crossref","first-page":"16134","DOI":"10.18632\/oncotarget.24743","article-title":"Regulation of breast cancer induced bone disease by cancer-specific IKKbeta","volume":"9","author":"Marino","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.05.021_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-4939-8997-3_7","article-title":"Analysis of signaling pathways by western blotting and immunoprecipitation","volume":"1914","author":"Marino","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2020.05.021_bib48","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M115.649608","article-title":"Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer induced osteolysis","author":"Sophocleous","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2020.05.021_bib49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jacc.2017.11.055","article-title":"Targeting CD40-induced TRAF6 signaling in macrophages reduces atherosclerosis","volume":"71","author":"Seijkens","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.canlet.2020.05.021_bib50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/bonekey.2014.59","article-title":"Quantitative analysis of bone and soft tissue by micro-computed tomography: applications to ex vivo and in vivo studies","volume":"3","author":"Campbell","year":"2014","journal-title":"BoneKEy Rep."},{"key":"10.1016\/j.canlet.2020.05.021_bib51","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/ijo.2014.198","article-title":"Blocking CD40-TRAF6 interactions by small-molecule inhibitor 6860766 ameliorates the complications of diet-induced obesity in mice","volume":"39","author":"van den Berg","year":"2015","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.canlet.2020.05.021_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12974-017-0875-9","article-title":"Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation","volume":"14","author":"Aarts","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.canlet.2020.05.021_bib53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jlb.61.4.381","article-title":"Osteoclasts, macrophages, and the molecular mechanisms of bone resorption","volume":"61","author":"Teitelbaum","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.canlet.2020.05.021_bib54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.canlet.2020.05.021_bib55","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2020.05.021_bib56","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1073\/pnas.1013492108","article-title":"Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand","volume":"108","author":"Li","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.05.021_bib57","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling","volume":"13","author":"Lomaga","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2020.05.021_bib58","series-title":"Proc Natl Acad Sci USA","first-page":"768","article-title":"Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand","author":"Li","year":"2011"},{"key":"10.1016\/j.canlet.2020.05.021_bib59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccr.2009.05.017","article-title":"Latent bone metastasis in breast cancer tied to Src-dependent survival signals","volume":"16","author":"Zhang","year":"2009","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2020.05.021_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccell.2014.11.025","article-title":"14-3-3zeta turns TGF-beta's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2","volume":"27","author":"Xu","year":"2015","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2020.05.021_bib61","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat.Rev.Cancer"},{"key":"10.1016\/j.canlet.2020.05.021_bib62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.canlet.2020.05.021_bib63","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10555-006-9023-1","article-title":"Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases","volume":"25","author":"Siclari","year":"2006","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.canlet.2020.05.021_bib64","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bone.2010.12.023","article-title":"RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II","volume":"48","author":"Hemingway","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2020.05.021_bib65","doi-asserted-by":"crossref","first-page":"75571","DOI":"10.18632\/oncotarget.12289","article-title":"IL-1 drives breast cancer growth and bone metastasis in vivo","volume":"7","author":"Holen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.05.021_bib66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1015872531675","article-title":"Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells","volume":"73","author":"Shibata","year":"2002","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.canlet.2020.05.021_bib67","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","article-title":"NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF","volume":"13","author":"Park","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2020.05.021_bib68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bone.2010.07.015","article-title":"Advances in the biology of bone metastasis: how the skeleton affects tumor behavior","volume":"48","author":"Sterling","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2020.05.021_bib69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","article-title":"Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy","volume":"10","author":"Kozlow","year":"2005","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.canlet.2020.05.021_bib70","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jcb.22799","article-title":"Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer","volume":"111","author":"Bussard","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2020.05.021_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2407-8-41","article-title":"NF-kappa B genes have a major role in inflammatory breast cancer","volume":"8","author":"Lerebours","year":"2008","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2020.05.021_bib72","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.05.021_bib73","doi-asserted-by":"crossref","first-page":"10044","DOI":"10.1158\/0008-5472.CAN-10-1254","article-title":"Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis","volume":"70","author":"Goldstein","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.05.021_bib74","doi-asserted-by":"crossref","first-page":"804347","DOI":"10.1155\/2015\/804347","article-title":"Interleukin-17 could promote breast cancer progression at several stages of the disease","volume":"2015","author":"Welte","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.canlet.2020.05.021_bib75","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/bcr2345","article-title":"Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis","volume":"11","author":"Das Roy","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2020.05.021_bib76","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1126\/science.1175065","article-title":"The E3 ligase TRAF6 regulates Akt ubiquitination and activation","volume":"325","author":"Yang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.canlet.2020.05.021_bib77","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1025905008934","article-title":"NF-kappaB in mammary gland development and breast cancer","volume":"8","author":"Cao","year":"2003","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.canlet.2020.05.021_bib78","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature09707","article-title":"Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling","volume":"470","author":"Tan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.05.021_bib79","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.4161\/cc.6.18.4721","article-title":"Inhibition of the canonical IKK\/NF kappa B pathway sensitizes human cancer cells to doxorubicin","volume":"6","author":"Tapia","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2020.05.021_bib80","doi-asserted-by":"crossref","first-page":"E601","DOI":"10.1073\/pnas.1316255111","article-title":"Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer","volume":"111","author":"Wei","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.05.021_bib81","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1074\/jbc.M109.078212","article-title":"IKK\u03b5 phosphorylation of estrogen receptor \u03b1 ser-167 and contribution to tamoxifen resistance in breast cancer*","volume":"285","author":"Guo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2020.05.021_bib82","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/360741a0","article-title":"Bone and haematopoietic defects in mice lacking c-fos","volume":"360","author":"Wang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.05.021_bib83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41598-017-18327-5","article-title":"TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis","volume":"8","author":"Peramuhendige","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2020.05.021_bib84","doi-asserted-by":"crossref","first-page":"34120","DOI":"10.1074\/jbc.273.51.34120","article-title":"The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily","volume":"273","author":"Galibert","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2020.05.021_bib85","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.05.021_bib86","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/MCB.26.3.1002-1013.2006","article-title":"Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2","volume":"26","author":"Kim","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2020.05.021_bib87","doi-asserted-by":"crossref","first-page":"28355","DOI":"10.1074\/jbc.273.43.28355","article-title":"The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor","volume":"273","author":"Wong","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2020.05.021_bib88","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2019.02.032","article-title":"Pharmacological inhibition of the IKKepsilon\/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer","volume":"450","author":"Bishop","year":"2019","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2020.05.021_bib89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2017.09.034","article-title":"Pharmacological evidence for the bone-autonomous contribution of the NFkappaB\/beta-catenin axis to breast cancer related osteolysis","volume":"410","author":"Marino","year":"2017","journal-title":"Canc. Lett."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520302822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520302822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:49:22Z","timestamp":1759592962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520302822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":89,"alternative-id":["S0304383520302822"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.05.021","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}